1232 PBMC humanized mouse model with clinical relevance in assessing the safety profile of 4–1BB agonist, urelumab, in 5 donors | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Regular and Young Investigator Award Abstracts

Immunotherapy Toxicities

1232 PBMC humanized mouse model with clinical relevance in assessing the safety profile of 4–1BB agonist, urelumab, in 5 donors

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

	Abstract	Full	Pdf
Nov 2023	132	0	17
Dec 2023	66	0	10
Jan 2024	33	0	5
Feb 2024	20	0	6
Mar 2024	46	0	16
Apr 2024	24	0	8
May 2024	28	0	3
Jun 2024	26	0	3
Jul 2024	36	0	6
Aug 2024	38	0	4
Sep 2024	22	0	2
Oct 2024	22	0	13
Nov 2024	34	0	8
Dec 2024	34	0	11
Jan 2025	30	0	8
Feb 2025	34	0	7
Mar 2025	0	0	8
Apr 2025	0	0	5
May 2025	0	0	5
Jun 2025	0	0	4
Total	625	0	149